微阵列分析市场 - 全球产业规模、份额、趋势、机会及预测（按产品和服务、类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球微阵列分析市场预计将从 2025 年的 56.8 亿美元成长到 2031 年的 92.3 亿美元，复合年增长率为 8.43%。

微阵列分析是一种高通量技术，它利用固体基板上的杂合反应探针，可同时检测基因表现或识别特定的DNA序列。市场扩张的主要驱动力是癌症和遗传性疾病等慢性病的盛行率上升，这些疾病需要快速诊断筛检。此外，对个人化医疗日益增长的需求以及药物研发领域的大量投资也持续推动着产业成长，为其在基因组分析和临床诊断领域的长期效用奠定了坚实的基础。

然而，市场正面临次世代定序技术的激烈竞争，这些技术解析度更高，成本效益也越来越高。随着医疗系统努力应对日益增长的疾病负担，这种竞争压力尤其严峻。根据美国癌症协会预测，到2025年，美国将新增2,041,910例癌症病例，这意味着对基因组分析的巨大需求，而微阵列技术必须在满足这一需求的同时，还要与更新、更先进的替代方案展开竞争。

市场驱动因素

癌症和遗传性疾病的日益普遍是推动微阵列分析技术应用的主要因素。随着临床医生和研究人员致力于揭示恶性肿瘤复杂的遗传基础，微阵列为高通量基因表现分析和比较基因组杂合反应提供了重要的基础。这项技术能够快速识别生物标记和染色体异常，这对于早期检测和疾病分型至关重要。根据国际癌症研究机构（IARC）2024年2月发布的新闻稿，全球癌症负担日益加重，预计2022年全球将新增约2,000万例癌症病例，并有970万人死于癌症。这种情况凸显了对强大的基因组分析工具的需求，以支持大规模人群筛检和分子病理学研究，即便新的竞争技术不断涌现。

同时，微阵列技术在药物发现和开发领域的应用日益广泛，显着地推动了市场成长。製药公司正广泛利用这些平台进行标靶检验和毒理基因组学研究，从而在分子层面评估临床前药物的安全性和有效性，进而减少后期研发失败，并简化繁琐的研发流程。欧洲製药工业协会联合会（EFPIA）2024年8月发布的报告也印证了推动这些活动的投资规模。该报告预测，2023年欧洲生物製药产业的研发投入将达到500亿欧元。此外，Illumina公司预计仅在2023财年，其微阵列业务的营收就将达到3.92亿美元，反映了该技术持续的商业性可行性。

市场挑战

来自次世代定序(NGS) 技术的日益激烈的竞争是全球微阵列分析市场成长的主要障碍。虽然微阵列提供了一个用于同时分析基因表现的平台，但它缺乏 NGS 的高分辨率能力，而 NGS 能够识别新的基因突变并进行更深入的基因组分析。随着医疗机构将诊断准确性置于优先地位，两种技术之间成本差距的缩小正在加速检测量从微阵列向定序平台的转移。这种替代效应限制了市场的潜在客户群，使微阵列的应用范围局限于小众领域，而 NGS 则占据了盈利的全球疾病谱分析市场。

近期产业应用数据也印证了这项技术变革的影响。根据美国病理学家协会 (CAP) 2024 年 11 月发布的一项临床基因组报告实务调查显示，所有受访的肿瘤检测均采用标靶基因组检测，而非基于晶片的方法。这种在癌症诊断中对基于定序的工作流程的根深蒂固的偏好，表明更具效用的新技术正在直接蚕食微阵列技术在关键临床应用中的市场份额。

市场趋势

蛋白质微阵列在蛋白质体学研究中的快速发展，标誌着研究策略正从DNA分析转向表型表征。高通量阵列使研究人员能够解析仅凭基因组数据无法阐明的生物学机制，促进了其在大规模人群研究中的应用。这一趋势在利用现代生物晶片多重分析能力的大规模生物银行专案中尤为明显。英国生物样本库在2025年1月发布的新闻稿中宣布启动一项大规模蛋白质研究，该计划检测60万个检体中的多达5,400种蛋白质，凸显了这项技术在生物标记发现和药物研发中日益增长的重要性。

同时，微阵列工作流程与次世代定序(NGS) 的整合正在建构全面的多组体学解决方案。主要企业正将基于微阵列的亲和性平台与定序基础设施结合，从而实现基因组和蛋白质组的同步分析，提供比任何单一技术整体情况。近期的一些策略性倡议凸显了这种整合趋势，例如 Standard Biotools 在 2025 年 11 月发布的财报中提到，该公司已于 2025 年 6 月将其 SomaLogic 业务出售给 Illumina。此类交易表明，业界正致力于将微阵列技术与定序系统融合，以提高诊断准确性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球微阵列分析市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品/服务分类（耗材、软体/服务、设备）
  • 按类型（DNA微阵列、蛋白质微阵列等）
  • 按应用领域（药物发现、疾病诊断、研究等）
  • 按最终用户（研究/学术机构、製药/生物技术公司、诊断实验室、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美微阵列分析市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲微阵列分析市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区微阵列分析市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东与非洲微阵列分析市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲微阵列分析市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球微阵列分析市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• Merck KGaA
• GE Healthcare Technologies, Inc.
• Danaher Corporation
• Arrayit Corporation
• Microarrays Inc.
• Bio-Rad Laboratories Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Microarray Analysis Market is projected to grow from USD 5.68 Billion in 2025 to USD 9.23 Billion by 2031, registering a CAGR of 8.43%. Microarray analysis serves as a high-throughput technology that utilizes hybridization probes on a solid substrate to simultaneously detect the expression of thousands of genes or identify specific DNA sequences. The market's expansion is primarily driven by the rising prevalence of chronic diseases, such as cancer and genetic disorders, which necessitates rapid diagnostic screening. Furthermore, the burgeoning demand for personalized medicine and significant investments in pharmaceutical research for drug discovery continue to bolster industry growth, providing a solid foundation for long-term utility in genomic analysis and clinical diagnostics.

However, the market confronts a significant challenge due to intense competition from Next-Generation Sequencing technologies, which offer higher resolution and are becoming increasingly cost-effective. This competitive pressure is particularly acute as healthcare systems strive to manage the growing disease burden. According to the American Cancer Society, 2,041,910 new cancer cases are projected to occur in the United States in 2025, indicating a massive demand for genomic profiling that microarrays must vie to fulfill against newer, more advanced alternatives.

Market Driver

The escalating prevalence of cancer and genetic disorders acts as a primary force propelling the adoption of microarray analysis. As clinicians and researchers strive to unravel the complex genetic underpinnings of malignancies, microarrays provide a critical platform for high-throughput gene expression profiling and comparative genomic hybridization. This technology facilitates the rapid identification of biomarkers and chromosomal aberrations essential for early detection and disease subtyping. According to the International Agency for Research on Cancer's February 2024 press release regarding the growing global cancer burden, there were approximately 20 million new cancer cases and 9.7 million deaths worldwide in 2022, necessitating robust genomic tools to support large-scale population screening and molecular pathology despite emerging competition.

Concurrently, the growing application of microarrays in pharmaceutical drug discovery and development is significantly fortifying market expansion. Pharmaceutical entities utilize these platforms extensively for target validation and toxicogenomics, enabling the assessment of drug safety and efficacy at the molecular level before clinical trials, which helps mitigate late-stage failures and streamlines the intensive R&D process. The scale of investment driving these activities is underscored by the European Federation of Pharmaceutical Industries and Associations' August 2024 report, which estimated that the research-based biopharmaceutical industry invested €50,000 million in R&D in Europe in 2023. Furthermore, Illumina, Inc. generated $392 million in revenue specifically from its microarray segment during fiscal year 2023, reflecting the sustained commercial viability of this technology.

Market Challenge

The intensified competition from Next-Generation Sequencing (NGS) technologies constitutes a formidable barrier to the growth of the Global Microarray Analysis Market. Although microarrays provide a platform for simultaneous gene expression analysis, they lack the high-resolution capabilities of NGS, which can identify novel genetic variants and provide deeper genomic insights. As healthcare providers prioritize diagnostic precision, the diminishing cost gap between these technologies is accelerating the migration of testing volumes from microarrays to sequencing platforms. This substitution effect restricts the market's addressable audience, confining microarrays to niche applications while NGS captures the lucrative segment of comprehensive disease profiling.

The impact of this technological shift is underscored by recent industry usage data. According to the College of American Pathologists, in November 2024, a study on clinical genomic reporting practices revealed that 100% of the reviewed oncology assays utilized targeted genomic panels rather than array-based methods. This entrenched preference for sequencing-based workflows in cancer diagnostics demonstrates how the superior utility of newer alternatives is directly eroding the market share of microarray technologies in critical clinical settings.

Market Trends

The rapid expansion of protein microarrays in proteomics research signifies a strategic shift beyond DNA analysis toward phenotypic characterization. Researchers utilizing high-throughput arrays can now decipher biological mechanisms that genomic data alone cannot reveal, driving adoption in large-scale population studies. This trend is exemplified by massive biobanking initiatives that leverage the multiplexing capabilities of modern biochips. According to a UK Biobank press release in January 2025 regarding the launch of a significant protein study, the organization announced a project to measure up to 5,400 proteins in each of 600,000 samples, highlighting the technology's growing centrality in biomarker discovery and drug development.

Concurrently, the integration of microarray workflows with Next-Generation Sequencing (NGS) is creating comprehensive multi-omic solutions. Key players are merging microarray-based affinity platforms with sequencing infrastructure to enable simultaneous interrogation of the genome and proteome, providing a holistic view of disease biology that isolated technologies cannot achieve. This consolidation is highlighted by recent strategic moves, such as Standard BioTools Inc.'s November 2025 financial results, which noted the sale of its SomaLogic business to Illumina, Inc. in June 2025. Such transactions illustrate the industry's push to unify microarray capabilities with sequencing ecosystems to enhance diagnostic precision.

Key Market Players

• Thermo Fisher Scientific Inc.
• Agilent Technologies Inc.
• Illumina Inc.
• PerkinElmer Inc.
• Merck KGaA
• GE Healthcare Technologies, Inc.
• Danaher Corporation
• Arrayit Corporation
• Microarrays Inc.
• Bio-Rad Laboratories Inc.

Report Scope

In this report, the Global Microarray Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microarray Analysis Market, By Product and Service

• Consumable
• Software and Service
• Instruments

Microarray Analysis Market, By Type

• DNA Microarrays
• Protein Microarrays
• others

Microarray Analysis Market, By Applications

• Drug Discovery
• Disease Diagnostic
• Research Applications
• others

Microarray Analysis Market, By End-User

• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• others

Microarray Analysis Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microarray Analysis Market.

Available Customizations:

Global Microarray Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microarray Analysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product and Service (Consumable, Software and Service, Instruments)
  • 5.2.2. By Type (DNA Microarrays, Protein Microarrays, others)
  • 5.2.3. By Applications (Drug Discovery, Disease Diagnostic, Research Applications, others)
  • 5.2.4. By End-User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Microarray Analysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product and Service
  • 6.2.2. By Type
  • 6.2.3. By Applications
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microarray Analysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product and Service
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Applications
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Microarray Analysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product and Service
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Applications
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Microarray Analysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product and Service
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Applications
      • 6.3.3.2.4. By End-User

7. Europe Microarray Analysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product and Service
  • 7.2.2. By Type
  • 7.2.3. By Applications
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microarray Analysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product and Service
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Applications
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Microarray Analysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product and Service
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Applications
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Microarray Analysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product and Service
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Applications
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Microarray Analysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product and Service
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Applications
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Microarray Analysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product and Service
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Applications
      • 7.3.5.2.4. By End-User

8. Asia Pacific Microarray Analysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product and Service
  • 8.2.2. By Type
  • 8.2.3. By Applications
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microarray Analysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product and Service
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Applications
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Microarray Analysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product and Service
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Applications
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Microarray Analysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product and Service
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Applications
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Microarray Analysis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product and Service
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Applications
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Microarray Analysis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product and Service
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Applications
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Microarray Analysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product and Service
  • 9.2.2. By Type
  • 9.2.3. By Applications
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microarray Analysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product and Service
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Applications
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Microarray Analysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product and Service
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Applications
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Microarray Analysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product and Service
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Applications
      • 9.3.3.2.4. By End-User

10. South America Microarray Analysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product and Service
  • 10.2.2. By Type
  • 10.2.3. By Applications
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microarray Analysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product and Service
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Applications
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Microarray Analysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product and Service
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Applications
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Microarray Analysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product and Service
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Applications
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microarray Analysis Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies Inc.
• 15.3. Illumina Inc.
• 15.4. PerkinElmer Inc.
• 15.5. Merck KGaA
• 15.6. GE Healthcare Technologies, Inc.
• 15.7. Danaher Corporation
• 15.8. Arrayit Corporation
• 15.9. Microarrays Inc.
• 15.10. Bio-Rad Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer